Back to Search Start Over

Kidney Biopsy Features Most Predictive of Clinical Outcomes in the Spectrum of Minimal Change Disease and Focal Segmental Glomerulosclerosis

Authors :
Zee, Jarcy
Liu, Qian
Smith, Abigail R.
Hodgin, Jeffrey B.
Rosenberg, Avi
Gillespie, Brenda W.
Holzman, Lawrence B.
Barisoni, Laura
Mariani, Laura H.
Adler, S.
Alter, G.
Athavale, A.
Atkinson, M.
Avila-Casado, C.
Bagnasco, S.
Baker, S.
Barisoni, L.
Bidot, C.
Blake, J.
Bray, M.
Canetta, P.
Chernitskiy, V.
Cooper, A.
Dell, K.
Dell, T.
Derebail, V.
Desmond, H.
Eddy, S.
Fermin, D.
Fervenza, F.
Flynn, P.
Fornoni, A.
Froment, A.
Gadegbeku, C.
Gaut, J.
Gibson, K.
Gillespie, B.
Gipson, D.
Greenbaum, L.
Hewitt, S.
Hingorani, S.
Hladunewich, M.
Hodgin, J.
Hogan, M.
Holzman, L.
Itteera, M.
Jefferson, A.
Kallem, K.
Kaskel, F.
Klida, C.
Kretzler, M.
Kopp, J.
Kretzler, M.
Kurtz, V.
Lafayette, R.
LaPage, J.
Larkina, M.
Lemley, K.
Lieske, J.
Li, S.
Li, S.
Lienczewski, C.C.
Lin, J.J.
Ling, P.
Liu, J.
Mainieri, T.
Mariani, L.
Meyers, K.
Modersitzki, F.
Morrison, S.
Nast, C.
Negrey, J.
Ormond-Foster, J.
Palmer, M.
Pao, E.
Pfaiff, M.
Pradhan, A.
Romano, M.
Rosenberg, A.
Royal, V.
Quinn-Boyle, S.
Reich, H.
Rogers, M.
Ross, M.
Sambandam, K.
Sampson, M.
Schachere, M.
Sedor, J.
Sethna, C.
Srivastava, T.
Smith, A.
Swenson, A.
Tang, S.
Thomas, D.
Trachtman, H.
Tuttle, K.
Vento, S.
Wang, C.
Wang, Z.
Williams, A.
Yeung, B.
Yun, E.
Zee, J.
Zhdanova, O.
Adler, S.
Alter, G.
Athavale, A.
Atkinson, M.
Avila-Casado, C.
Bagnasco, S.
Baker, S.
Barisoni, L.
Bidot, C.
Blake, J.
Bray, M.
Canetta, P.
Cassol, C.
Chernitskiy, V.
Cooper, A.
Dell, K.
Dell, T.
Demeke, D.
Derebail, V.
Desmond, H.
Eddy, S.
Fermin, D.
Fervenza, F.
Flynn, P.
Fornoni, A.
Froment, A.
Gadegbeku, C.
Gaut, J.
Gibson, K.
Gillespie, B.
Gipson, D.
Greenbaum, L.
Hewitt, S.
Hingorani, S.
Hladunewich, M.
Hodgin, J.
Hogan, M.
Holanda, D.
Holzman, L.
Itteera, M.
Jefferson, A.
Kallem, K.
Kaskel, F.
Klida, C.
Kopp, J.
Kretzler, M.
Kurtz, V.
Lafayette, R.
LaPage, J.
Larkina, M.
Lemley, K.
Lieske, J.
Li, S.
Li, S.
Lienczewski, C.C.
Lin, J.J.
Ling, P.
Liu, J.
Mainieri, T.
Mariani, L.
Messias, N.
Meyers, K.
Michailov, A.
Modersitzki, F.
Morrison, S.
Nast, C.
Negrey, J.
Ormond-Foster, J.
Palmer, M.
Pao, E.
Pfaiff, M.
Pradhan, A.
Romano, M.
Rosenberg, A.
Royal, V.
Quinn-Boyle, S.
Reich, H.
Rogers, M.
Ross, M.
Sambandam, K.
Sampson, M.
Schachere, M.
Sedor, J.
Sethna, C.
Srivastava, T.
Smith, A.
Swenson, A.
Tang, S.
Thomas, D.
Trachtman, H.
Tuttle, K.
Vento, S.
Wang, C.
Wang, Z.
Williams, A.
Yamashita, M.
Yeung, B.
Yun, E.
Zee, J.
Zhdanova, O.
Zuo, Y.
Source :
Journal of the American Society of Nephrology; July 2022, Vol. 33 Issue: 7 p1411-1426, 16p
Publication Year :
2022

Abstract

The classification of podocytopathies, including minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS), has historically been based on limited glomerular features. This study used supervised machine learning methods to identify the most important clinical and histopathologic predictors of disease progression, complete proteinuria remission, and treatment response in MCD/FSGS. The top predictors included conventional and novel glomerular and tubulointerstitial features. Biopsy reporting for podocytopathies should be standardized by including these prognostic morphologic features to inform risk stratification.

Details

Language :
English
ISSN :
10466673 and 15333450
Volume :
33
Issue :
7
Database :
Supplemental Index
Journal :
Journal of the American Society of Nephrology
Publication Type :
Periodical
Accession number :
ejs61660069
Full Text :
https://doi.org/10.1681/ASN.2021101396